Legence shares are moving higher as investors respond to a new round of bullish sell-side revisions in April, including a maintained Buy rating with a higher $72 price target issued on April 16, 2026. The stock’s gains also reflect a continued shift in focus back to operating momentum—especially management’s raised 2026 targets and visibility supported by a record backlog—after the early-April secondary offering headlines passed through the market.

Legence’s most recent results set the tone for the rally: the company reported Q4 and full-year 2025 performance on March 27, 2026, and paired it with guidance that implied accelerating scale into 2026, while pointing to a record backlog of $3.7 billion. In April, selling stockholders affiliated with Blackstone completed an upsized secondary offering priced at $54.00 per share, culminating in the April 9, 2026 closing; Legence itself did not issue shares and received no proceeds, but the added float temporarily increased supply and became a short-term trading overhang that is now fading.

With LGN now well above the April secondary price, the next debate is whether multiple expansion is justified by execution rather than sentiment. Investors will likely monitor (1) conversion of backlog into revenue, (2) margin trajectory implied by adjusted EBITDA guidance, and (3) acquisition/integration cadence as Legence expands in mission-critical end markets such as data centers and other technically demanding facilities.